Quindoline, perylene and coronenen derivatives have been reported to downregulate Bcl-2 transcription and promoter activity and to induce apoptosis in cancer models but with a promiscuous mechanism of action affecting also other biological targets, such as telomeric and other oncogenic G4 [175,176]. Here, BCL2 is linked to cancer.